Patents by Inventor Michael R. Hamblin

Michael R. Hamblin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11135445
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: October 5, 2021
    Assignee: The General Hospital Corporation
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey A. Gelfand, Timothy Brauns
  • Publication number: 20200360043
    Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.
    Type: Application
    Filed: July 7, 2020
    Publication date: November 19, 2020
    Inventors: Richard Rox Anderson, William A. Farinelli, Michael R. Hamblin, Dieter Manstein
  • Patent number: 10780294
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: September 22, 2020
    Assignee: The General Hospital Corporation
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Jeffrey Gelfand, Timothy Brauns
  • Patent number: 10716591
    Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: July 21, 2020
    Assignee: The General Hospital Corporation
    Inventors: Richard Rox Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
  • Publication number: 20190175933
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Application
    Filed: February 15, 2019
    Publication date: June 13, 2019
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
  • Publication number: 20180036029
    Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.
    Type: Application
    Filed: October 17, 2017
    Publication date: February 8, 2018
    Inventors: Richard Rox ANDERSON, Michael R. HAMBLIN, Dieter MANSTEIN, William A. FARINELLI
  • Publication number: 20180036552
    Abstract: A problem of incomplete inhibition of harmful cells/bacteria and short duration of time, after the photodynamic treatment, during which such cells may re-grow, is solved by exposing the target bacteria with a multi-component photosensitizer material formed by adding a predetermined potentiating chemical to a conventional single-component photosensitizer at the target, prior to irradiating the target with light. The multi-component photosensitizer is effectuated by forming a mix of the two chemical compositions or by sequential exposure of the bacteria to a single-component photosensitizer and the potentiating chemical of choice.
    Type: Application
    Filed: November 18, 2015
    Publication date: February 8, 2018
    Inventors: Daniela Vecchio, Michael R. Hamblin, Yingying Huang, Liyi Huang, Giacomo Landi, Geoffrey Gelfand, Timothy Brauns
  • Patent number: 9827006
    Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: November 28, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Richard R. Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
  • Publication number: 20130115133
    Abstract: The present invention relates the use of phenothiaziniums and microbial MDR inhibitors to inactivate microorganisms. Methods of the present invention are useful in the treatment of living subjects and in the decontamination of inanimate objects and substances.
    Type: Application
    Filed: June 19, 2012
    Publication date: May 9, 2013
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Michael R. Hamblin, George P. Tegos
  • Publication number: 20120264802
    Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.
    Type: Application
    Filed: May 31, 2012
    Publication date: October 18, 2012
    Applicants: Lynntech, Inc., The General Hospital Corporation
    Inventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
  • Patent number: 8207211
    Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: June 26, 2012
    Assignees: The General Hospital Corporation, Lynntech, Inc.
    Inventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
  • Publication number: 20120041430
    Abstract: Exemplary embodiments of apparatus and method for harvesting small portions of tissue (“micrografts”) to form grafts can be provided. For example, a hollow tube can be inserted into tissue at a donor site, where a distal end of the hollow tube can have two or more points or extensions to facilitate separation of the micrografts from the surrounding tissue. The exemplary apparatus can be provided that includes a plurality of such tubes for simultaneous harvesting of a plurality of micrografts. The harvested micrografts can have a small dimension, e.g., less than about 1 mm, or less than about 0.3 mm, which can promote healing of the donor site and/or viability of the harvested tissue. The micrografts can be approximately cylindrical or strip-shaped, and can be placed in a biocompatible matrix to form a graft or directly into tissue at the recipient site. Such exemplary micrografts can be obtained from skin or other types of tissue, e.g., various internal organs.
    Type: Application
    Filed: April 1, 2009
    Publication date: February 16, 2012
    Applicant: The General Hospital Corporation
    Inventors: Richard R. Anderson, Michael R. Hamblin, Dieter Manstein, William A. Farinelli
  • Publication number: 20100184818
    Abstract: The present invention provides photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.
    Type: Application
    Filed: April 15, 2008
    Publication date: July 22, 2010
    Applicants: THE GENERAL HOSPITAL CORPORATION, LYNNTECH, INC.
    Inventors: John Timothy Wharton, Hariprasad Gali, Michael R. Hamblin, Pawel Mroz
  • Publication number: 20090076115
    Abstract: The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.
    Type: Application
    Filed: February 28, 2006
    Publication date: March 19, 2009
    Applicants: The General Hospital Corporation, Lynntech, Inc.
    Inventors: Tim Wharton, Hariprasad Gali, Michael R. Hamblin
  • Publication number: 20080260650
    Abstract: The present invention relates to methods for the detection and therapy of inflamed tissue, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by inflammatory cells.
    Type: Application
    Filed: October 27, 2005
    Publication date: October 23, 2008
    Applicant: THE GENERAL HOSPITAL Corporation
    Inventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand
  • Publication number: 20080193376
    Abstract: The present invention relates to methods for the detection and therapy of active atheromatous plaques, and in particular vulnerable plaques, whereby immune modulators are used to increase the uptake of diagnostic or therapeutic compositions by the inflammatory cells associated with such plaques.
    Type: Application
    Filed: October 28, 2004
    Publication date: August 14, 2008
    Applicant: The General Hospital Corporation
    Inventors: Ahmed Tawakol, Michael R. Hamblin, Raymond Q. Migrino, Jeffrey Gelfand
  • Publication number: 20080166304
    Abstract: The present invention relates to the use of phenothiaziniums and microbial MDR inhibitors to inactivate microorganisms. Methods of the present invention are useful in the treatment of living subjects and in the decontamination of inanimate objects and substances.
    Type: Application
    Filed: September 19, 2005
    Publication date: July 10, 2008
    Applicant: The General Hospital Corpoartion
    Inventors: Michael R. Hamblin, George P. Tegos
  • Patent number: 7268155
    Abstract: Conjugate molecules which include photosensitizer compositions conjugated to non-antibody non-affinity pair targeting moieties and methods of making and using such conjugates are described.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: September 11, 2007
    Assignee: The General Hospital Corporation
    Inventors: Tayyaba Hasan, Michael R. Hamblin, Nikos Soukos
  • Patent number: 7077839
    Abstract: Various tissue glues have drawback such as toxicity, causing inflammatory reactions or insufficient bonding strength. The present invention is directed to methods of form tissue adhesion by administering to tissues compositions comprising proteins conjugated to one or more novel photosensitizers and irradiating the composition. The composition may further comprise one or more proteins not conjugated to the photosensitizer. Additionally, the present invention relates to compositions and methods wherein increased ratios of protein to photosensitizer enhance weld strength.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: July 18, 2006
    Assignee: General Hospital Corporation
    Inventors: Michael R. Hamblin, John Khadem
  • Publication number: 20030216718
    Abstract: Various tissue glues have drawback such as toxicity, causing inflammatory reactions or insufficient bonding strength. The present invention is directed to methods of form tissue adhesion by administering to tissues compositions comprising proteins conjugated to one or more novel photosensitizers and irradiating the composition. The composition may further comprise one or more proteins not conjugated to the photosensitizer. Additionally, the present invention relates to compositions and methods wherein increased ratios of protein to photosensitizer enhance weld strength.
    Type: Application
    Filed: June 16, 2003
    Publication date: November 20, 2003
    Inventors: Michael R. Hamblin, John J. Khadem